chest xray_TS_182156946 Patients with mild-to-moderate airflow limitations should be screened for COPD exacerbations. In patients with mild-to-moderate COPD, exacerbation is associated with the ...

SGLT2 inhibitors and GLP-1 receptor agonists were associated with fewer exacerbations of COPD in adults with type 2 diabetes. There was little difference between SGLT2 inhibitors and GLP-1 receptor ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. At the moment, targeted lung denervation as a treatment ...

Please provide your email address to receive an email when new articles are posted on . The rate of exacerbation was 46.8% in the group using metformin and 63% in the group not using metformin. The ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic phenotype. Some 20% to 40% of COPD patients have elevated blood eosinophil counts ...

Patients with chronic obstructive pulmonary disease (COPD) face a significant cardiovascular burden both before and after diagnosis. Analyses presented at the European Respiratory Society (ERS) ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage to the airways. It typically refers to emphysema and chronic bronchitis.

Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the ...

Almost 16 million adults have COPD in the United States and about 3 in 4 people with this condition have at least one flare (exacerbation) a year, cites a review. But you don’t have to sit and wait ...

“I live with COPD, and I have experienced the emotional and physical toll it takes. Sadly, the status quo is unacceptable. We sorely need improved and new therapeutic approaches that will enable us to ...

About The Study: Among people with chronic obstructive pulmonary disease (COPD) at high risk of exacerbation, treatment with the β1-selective β-blocker bisoprolol did not reduce the number of ...

March 18, 2010 — Pharmacotherapy, ventilation strategies, and other management issues regarding chronic obstructive pulmonary disease (COPD) exacerbations are reviewed in an article published in the ...